Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current EKNCF market cap is 0. The company's latest EPS is JPY and P/E is N/A.
| Year End 31 March 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | |
| Total Revenue | 36.59B | 38.67B | 43B | 43.27B | 40.05B |
| Operating Income | 4.62B | 6.61B | 8.39B | 7.46B | 3.38B |
| Net Income | 3.54B | 5.04B | 6.22B | 5.74B | 2.63B |
| Year End 31 March 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | |
| Total Assets | 50.32B | 55.69B | 62.51B | 66.28B | 61.65B |
| Total Liabilities | 13.02B | 14.01B | 16.71B | 16.74B | 15.68B |
| Total Equity | 37.3B | 41.67B | 45.8B | 49.54B | 45.97B |
| Year End 31 March 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | |
| Operating | 5.46B | 5.45B | 7.77B | 7.57B | 3.81B |
| Investing | -3.71B | -2.19B | -5.04B | -315M | -2.22B |
| Financing | -1.22B | -1.28B | 1.2B | -2.1B | -6.69B |
| Market Cap | 0 |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 40.04M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0 (0%) |
| Company Name | Eiken Chemical Company Ltd (PK) |
| Address |
yamaguchi bldg 7 taito, tokyo 110-8408 |
| Website | https://www.eiken.co.jp |
| Industry | pharmaceutical diversified (H2) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
